BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 15519278)

  • 1. The multifactorial nature of HIV-1 latency.
    Lassen K; Han Y; Zhou Y; Siliciano J; Siliciano RF
    Trends Mol Med; 2004 Nov; 10(11):525-31. PubMed ID: 15519278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency].
    Schwartz C; Le Douce V; Cherrier T; Redel L; Marban C; Aunis D; Rohr O
    Med Sci (Paris); 2010 Feb; 26(2):159-63. PubMed ID: 20188047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental approaches to the study of HIV-1 latency.
    Han Y; Wind-Rotolo M; Yang HC; Siliciano JD; Siliciano RF
    Nat Rev Microbiol; 2007 Feb; 5(2):95-106. PubMed ID: 17224919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Molecular Basis for Human Immunodeficiency Virus Latency.
    Mbonye U; Karn J
    Annu Rev Virol; 2017 Sep; 4(1):261-285. PubMed ID: 28715973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host factors regulating post-integration latency of HIV.
    Williams SA; Greene WC
    Trends Microbiol; 2005 Apr; 13(4):137-9. PubMed ID: 15817380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.
    Chan CN; Trinité B; Lee CS; Mahajan S; Anand A; Wodarz D; Sabbaj S; Bansal A; Goepfert PA; Levy DN
    Retrovirology; 2016 Jan; 13():1. PubMed ID: 26728316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells.
    Zhou Y; Zhang H; Siliciano JD; Siliciano RF
    J Virol; 2005 Feb; 79(4):2199-210. PubMed ID: 15681422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Viral latency of HIV-1].
    Bouchat S; Van Lint C
    Virologie (Montrouge); 2019 Aug; 23(4):195-210. PubMed ID: 31414658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency.
    Huang H; Santoso N; Power D; Simpson S; Dieringer M; Miao H; Gurova K; Giam CZ; Elledge SJ; Zhu J
    J Biol Chem; 2015 Nov; 290(45):27297-27310. PubMed ID: 26378236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of human immunodeficiency virus-1 latency and its reactivation.
    Verdin E
    Bull Mem Acad R Med Belg; 2008; 163(6):355-64; discussion 364-5. PubMed ID: 19445107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The KAT5-Acetyl-Histone4-Brd4 axis silences HIV-1 transcription and promotes viral latency.
    Li Z; Mbonye U; Feng Z; Wang X; Gao X; Karn J; Zhou Q
    PLoS Pathog; 2018 Apr; 14(4):e1007012. PubMed ID: 29684085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latency: the hidden HIV-1 challenge.
    Marcello A
    Retrovirology; 2006 Jan; 3():7. PubMed ID: 16412247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underlying mechanisms of HIV-1 latency.
    Romani B; Allahbakhshi E
    Virus Genes; 2017 Jun; 53(3):329-339. PubMed ID: 28258391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo.
    Lassen KG; Bailey JR; Siliciano RF
    J Virol; 2004 Sep; 78(17):9105-14. PubMed ID: 15308706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells.
    Thibault S; Imbeault M; Tardif MR; Tremblay MJ
    Virology; 2009 Jun; 389(1-2):20-5. PubMed ID: 19447460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 integration landscape during latent and active infection.
    Cohn LB; Silva IT; Oliveira TY; Rosales RA; Parrish EH; Learn GH; Hahn BH; Czartoski JL; McElrath MJ; Lehmann C; Klein F; Caskey M; Walker BD; Siliciano JD; Siliciano RF; Jankovic M; Nussenzweig MC
    Cell; 2015 Jan; 160(3):420-32. PubMed ID: 25635456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
    Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
    Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes.
    Han Y; Lassen K; Monie D; Sedaghat AR; Shimoji S; Liu X; Pierson TC; Margolick JB; Siliciano RF; Siliciano JD
    J Virol; 2004 Jun; 78(12):6122-33. PubMed ID: 15163705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy.
    Ikeda T; Shibata J; Yoshimura K; Koito A; Matsushita S
    J Infect Dis; 2007 Mar; 195(5):716-25. PubMed ID: 17262715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli.
    Swiggard WJ; Baytop C; Yu JJ; Dai J; Li C; Schretzenmair R; Theodosopoulos T; O'Doherty U
    J Virol; 2005 Nov; 79(22):14179-88. PubMed ID: 16254353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.